Cytosolix Inc.

Cytosolix is a platform that produces novel derivatives of known small-molecule oncology drugs. These derivatives selectively target cancer cells by targeting acidity in the tumor microenvironment, significantly improving the efficacy of treatment by reducing dose-limiting toxicities.